找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊CLINICAL CANCER RESEARCH 2024/2025影响因子:10.165 (CLIN CANCER RES) (1078-0432). (ONCOLOGY)(肿瘤学)Science Citation Inde

[复制链接]
楼主: HARDY
发表于 2025-3-23 11:49:59 | 显示全部楼层
发表于 2025-3-23 14:39:21 | 显示全部楼层
Submitted on: 19 July 2022. Revised on: 10 September 2022. Accepted on: 04 November 2022. ___________________CLINICAL CANCER RESEARCH---AMER ASSOC CANCER RESEARCH
发表于 2025-3-23 19:37:26 | 显示全部楼层
Submitted on: 10 October 2003. Revised on: 28 November 2003. Accepted on: 25 January 2004. ___________________CLINICAL CANCER RESEARCH---AMER ASSOC CANCER RESEARCH
发表于 2025-3-23 22:13:02 | 显示全部楼层
发表于 2025-3-24 03:53:25 | 显示全部楼层
Submitted on: 19 February 2019. Revised on: 17 March 2019. Accepted on: 27 March 2019. ___________________CLINICAL CANCER RESEARCH---AMER ASSOC CANCER RESEARCH
发表于 2025-3-24 09:20:41 | 显示全部楼层
发表于 2025-3-24 12:30:07 | 显示全部楼层
Submitted on: 20 September 2019. Revised on: 23 November 2019. Accepted on: 18 December 2019. ___________________CLINICAL CANCER RESEARCH---AMER ASSOC CANCER RESEARCH
发表于 2025-3-24 15:01:05 | 显示全部楼层
发表于 2025-3-24 20:02:50 | 显示全部楼层
Submitted on: 01 November 2020. Revised on: 18 January 2021. Accepted on: 24 February 2021. ___________________CLINICAL CANCER RESEARCH---AMER ASSOC CANCER RESEARCH
发表于 2025-3-25 01:51:42 | 显示全部楼层
Submitted on: 15 August 2011. Revised on: 13 November 2011. Accepted on: 06 January 2012. ___________________CLINICAL CANCER RESEARCH---AMER ASSOC CANCER RESEARCH
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-5 01:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表